JP2010536366A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536366A5
JP2010536366A5 JP2010521581A JP2010521581A JP2010536366A5 JP 2010536366 A5 JP2010536366 A5 JP 2010536366A5 JP 2010521581 A JP2010521581 A JP 2010521581A JP 2010521581 A JP2010521581 A JP 2010521581A JP 2010536366 A5 JP2010536366 A5 JP 2010536366A5
Authority
JP
Japan
Prior art keywords
ebi3
level
lung cancer
nptx1
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010521581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536366A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2008/065352 external-priority patent/WO2009028580A1/en
Publication of JP2010536366A publication Critical patent/JP2010536366A/ja
Publication of JP2010536366A5 publication Critical patent/JP2010536366A5/ja
Pending legal-status Critical Current

Links

JP2010521581A 2007-08-24 2008-08-21 肺癌の治療及び診断の標的遺伝子のためのebi3、dlx5、nptx1、及びcdkn3 Pending JP2010536366A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95795607P 2007-08-24 2007-08-24
US97736007P 2007-10-03 2007-10-03
PCT/JP2008/065352 WO2009028580A1 (en) 2007-08-24 2008-08-21 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis

Publications (2)

Publication Number Publication Date
JP2010536366A JP2010536366A (ja) 2010-12-02
JP2010536366A5 true JP2010536366A5 (cg-RX-API-DMAC7.html) 2012-10-18

Family

ID=40387295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010521581A Pending JP2010536366A (ja) 2007-08-24 2008-08-21 肺癌の治療及び診断の標的遺伝子のためのebi3、dlx5、nptx1、及びcdkn3

Country Status (10)

Country Link
US (1) US20110152345A1 (cg-RX-API-DMAC7.html)
EP (1) EP2198021A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010536366A (cg-RX-API-DMAC7.html)
KR (1) KR20100075857A (cg-RX-API-DMAC7.html)
CN (1) CN101835894A (cg-RX-API-DMAC7.html)
BR (1) BRPI0815769A2 (cg-RX-API-DMAC7.html)
CA (1) CA2697513A1 (cg-RX-API-DMAC7.html)
RU (1) RU2010111120A (cg-RX-API-DMAC7.html)
TW (1) TW200920406A (cg-RX-API-DMAC7.html)
WO (1) WO2009028580A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
WO2011145085A2 (en) * 2010-05-21 2011-11-24 Procognia (Israel) Ltd Novel antibodies and methods of use for the treatment and diagnosis of cancer
EP2577313A1 (en) * 2010-06-03 2013-04-10 Porto Conte Ricerche S.r.l. Biomarkers for lung neuroendocrine tumors
AU2011316986A1 (en) * 2010-10-20 2013-06-06 Rush University Medical Center Lung cancer tests
US20120295803A1 (en) * 2011-05-16 2012-11-22 The Regents Of The University Of Michigan Lung cancer signature
US20140220006A1 (en) * 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers
US9753037B2 (en) 2013-03-15 2017-09-05 Rush University Medical Center Biomarker panel for detecting lung cancer
US20150038365A1 (en) * 2013-08-01 2015-02-05 Meso Scale Technologies, Llc Lung cancer biomarkers
WO2015088947A1 (en) 2013-12-09 2015-06-18 Rush University Medical Center Biomarkers of rapid progression in advanced non-small cell lung cancer
KR101583673B1 (ko) 2014-02-28 2016-01-08 이화여자대학교 산학협력단 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 dlx5
KR101601941B1 (ko) 2014-02-28 2016-03-09 이화여자대학교 산학협력단 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 mta3
KR101601942B1 (ko) 2014-02-28 2016-03-09 이화여자대학교 산학협력단 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 tet1
KR101601943B1 (ko) 2014-02-28 2016-03-09 이화여자대학교 산학협력단 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 uchl1
CN109406782A (zh) * 2016-05-11 2019-03-01 卢氏实验室公司 一种快速诊断和监控肺癌的免疫层析检测条及其制备方法
CN108182346B (zh) * 2016-12-08 2021-07-30 杭州康万达医药科技有限公司 预测siRNA针对某类细胞的毒性的机器学习模型的建立方法及其应用
MX2020001958A (es) * 2017-08-21 2020-09-25 Savicell Diagnostic Ltd Procedimientos de diagnostico y tratamiento del cancer de pulmon.
CN116059349A (zh) * 2018-01-26 2023-05-05 国立大学法人东海国立大学机构 靶点为受体蛋白的治疗药物、检测药物、与受体蛋白结合的抗体及分子靶向药物的筛选方法
SG10201802979VA (en) * 2018-04-10 2019-11-28 Kah Meng Lim Immunological extract and method of production
CN110938129B (zh) * 2019-11-08 2021-07-13 上海交通大学 一种生物活性多肽sklvpvgygirkl及其制备方法和应用
CN111116744A (zh) * 2020-01-07 2020-05-08 长江大学 哺乳动物eEF1Bα蛋白磷酸化Ser106位点的特异性抗体的制备方法及其应用
EP4695283A1 (en) * 2023-04-14 2026-02-18 Technische Universität München, in Vertretung des Freistaats Bayern Method for producing the subunits of human interleukin 35 from interleukin 12 and interleukin 27
EP4635983A1 (en) * 2024-04-15 2025-10-22 Ymmunobio AG A novel antibody binding specifically to nptxr and use thereof

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2226575C (en) 1995-07-27 2011-10-18 Genentech, Inc. Stabile isotonic lyophilized protein formulation
WO1997013589A1 (en) * 1995-10-10 1997-04-17 Minnesota Mining And Manufacturing Company Corrosion protection coating system
US5770380A (en) 1996-09-13 1998-06-23 University Of Pittsburgh Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US20050089932A1 (en) 2001-04-26 2005-04-28 Avidia Research Institute Novel proteins with targeted binding
US20050053973A1 (en) 2001-04-26 2005-03-10 Avidia Research Institute Novel proteins with targeted binding
US20050048512A1 (en) 2001-04-26 2005-03-03 Avidia Research Institute Combinatorial libraries of monomer domains
JP4369662B2 (ja) 2001-04-26 2009-11-25 アビディア インコーポレイテッド 単量体ドメインのコンビナトリアルライブラリー
US20040175756A1 (en) 2001-04-26 2004-09-09 Avidia Research Institute Methods for using combinatorial libraries of monomer domains
US20040038877A1 (en) * 2001-10-02 2004-02-26 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
AU2003249012A1 (en) * 2002-09-30 2004-04-23 Japan As Represented By The President Of The University Of Tokyo Genes and polypeptides relating to human myeloid leukemia
AU2003224132A1 (en) * 2003-04-24 2004-11-19 Galapagos Genomics N.V. Effective sirna knock-down constructs
EP2343384A3 (en) * 2004-03-23 2012-01-04 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancer
DK1781787T3 (en) 2004-08-23 2017-07-31 Sylentis Sau TREATMENT OF EYE DISORDERS FEATURED BY AN INCREASED INTRAOCULAR PRESSURE WITH SIRNAS
US7998695B2 (en) * 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
US7932032B2 (en) * 2005-05-02 2011-04-26 Toray Industries, Inc. Method for diagnosing esophageal cancer
US7504225B2 (en) * 2005-05-12 2009-03-17 Applied Genomics, Inc. Reagents and methods for use in cancer diagnosis, classification and therapy
EP1907582B1 (en) * 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
DE102005049800B4 (de) * 2005-10-18 2009-09-17 Johannes-Gutenberg-Universität Mainz Verfahren zur Auffindung von Inhibitoren des Epstein-Barr-Virus-induzierten Gens 3 (EBI 3) und deren Verwendungen bei der Behandlung von metastasierenden Tumoren und allergischem Asthma
EP3147665A1 (en) * 2005-12-22 2017-03-29 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
EP2061900A2 (en) * 2006-08-25 2009-05-27 Oncotherapy Science, Inc. Prognostic markers and therapeutic targets for lung cancer

Similar Documents

Publication Publication Date Title
JP4425141B2 (ja) 非小細胞肺癌の診断のための方法
JP5109131B2 (ja) 膀胱癌を診断する方法
US20110152345A1 (en) Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
JP6014904B2 (ja) Erap1由来ペプチド及びその使用
US20110263012A1 (en) Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex
JP2010512730A (ja) 肺癌の腫瘍マーカーおよび治療標的としてのttk
CN110302382A (zh) 一种靶向肿瘤细胞的药物
AU2011292809B2 (en) BARD1 isoforms in lung and colorectal cancer and use thereof
US20120322075A1 (en) Lung Tumor Markers and Methods of Use Thereof
US20100184047A1 (en) Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex
US9822184B2 (en) DCLK1 short form specific binding agents
US20110165178A1 (en) Diagnosis of prostate cancer
JP2010501162A (ja) 肺癌の治療標的及び予後指標としてのimp−1癌遺伝子
JP6057408B2 (ja) 癌の予防剤および/または治療剤
JP2012501168A (ja) 腫瘍マーカー及び癌に対する治療標的としてのtbc1d7
US20120195916A1 (en) Method of treating cancer by inhibiting trim59 expression or activity
RU2813996C2 (ru) Слитый белок из белка dctn1 с белком ret
HK40072991B (en) The use of ttpal as a marker for monitoring or prognosis determination of gastric cancer
CN110241218A (zh) 一种检测适用靶向p53的抗癌药的肿瘤患者的试剂盒
HK1227995B (en) Bard1 isoforms in lung and colorectal cancer, detection method and use thereof